Tecentriq, an Anti-PD-L1 Antibody, Receives Approval for Additional Indication of Extensive-Stage Small Cell Lung Cancer
2019-08-22
Dear Investor,
Please find attached a press release by Chugai.
Do not hesitate to contact us for any further questions.
Investors
Investor updates
stay updated
get the latest news and updates to your inbox.